These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The rabbit syndrome. A peculiar extrapyramidal reaction. Villeneuve A Can Psychiatr Assoc J; 1972; 17(2):Suppl 2:SS69-. PubMed ID: 5042912 [No Abstract] [Full Text] [Related]
5. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction. Randrup A Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170 [No Abstract] [Full Text] [Related]
6. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias). Marsden CD Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927 [No Abstract] [Full Text] [Related]
7. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses? Neu C; Dimascio A; Demirgian E Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975 [No Abstract] [Full Text] [Related]
9. Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat. Poirier LJ; Langelier P; Bédard P; Boucher R; Larochelle L; Parent A; Roberge AG Adv Neurol; 1974; 5():5-10. PubMed ID: 4216259 [No Abstract] [Full Text] [Related]
10. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)]. Bourgeois M; Bouey P Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864 [No Abstract] [Full Text] [Related]
11. Coexisting tardive dyskinesia and parkinsonism: a case report. De Fraites EG; Davis KL; Berger PA Biol Psychiatry; 1977 Apr; 12(2):267-72. PubMed ID: 857938 [TBL] [Abstract][Full Text] [Related]
12. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics. Klett CJ; Caffey E Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131 [No Abstract] [Full Text] [Related]
14. Pharmacotherapy of schizophrenia. Ban TA Curr Psychiatr Ther; 1976; 16():163-75. PubMed ID: 991627 [No Abstract] [Full Text] [Related]
15. Three types of akinesia in the progressive course of Parkinson's disease. Narabayashi H Adv Neurol; 1993; 60():18-24. PubMed ID: 8093577 [No Abstract] [Full Text] [Related]
16. [Study of extrapyramidal manifestations induced by neuroleptics]. Bordeleau JM; Tétreault L Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291 [No Abstract] [Full Text] [Related]
17. [Cellular effect of neuroleptics]. Kuschinsky K Dtsch Med Wochenschr; 1975 Jun; 100(25):1405-8. PubMed ID: 237751 [No Abstract] [Full Text] [Related]
18. Extrapyramidal symptoms in the course of fluphenazine treatment. Bastecký J; Vinar O; Taussigová D Act Nerv Super (Praha); 1972; 14(2):97-9. PubMed ID: 5040184 [No Abstract] [Full Text] [Related]
19. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action. Huygens H; Vereecken JL; Tanghe A Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374 [No Abstract] [Full Text] [Related]
20. [The role of dopamine in the physiology and pathology of the basal ganglia]. Arushanian EB Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763 [No Abstract] [Full Text] [Related] [Next] [New Search]